Merck KGaA Buys Bio-Techne for $11.3B; TECH Pops 20%
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.
life sciences m&a
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.